[1] Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b.
Hofmann H, Flöss S, Stamminger T.
J Virol. 2000 Mar;74(6):2510-24. [
PMID: 10684265]
[2] Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Ahn JH, Xu Y, Jang WJ, Matunis MJ, Hayward GS.
J Virol. 2001 Apr;75(8):3859-72. [
PMID: 11264375]
[3] Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin.
Rallabhandi P, Hashimoto K, Mo YY, Beck WT, Moitra PK, D'Arpa P.
J Biol Chem. 2002 Oct 18;277(42):40020-6. [
PMID: 12149243]
[4] Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.
Berndt A, Hofmann-Winkler H, Tavalai N, Hahn G, Stamminger T.
J Virol. 2009 Dec;83(24):12881-94. [
PMID: 19812159]